| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |